In colon cancer, EpICD was found to interact with β-catenin and hypoxia inducible factor 1α (HIF-1α) to promote the transcriptional activity of HIF-1α-targeted genes (Fig. 2c) [19]. The gene discussed is HIF1A; the disease is colonic neoplasm.